Patent details

Basic Information

Publication number:

EP2394702

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111803300

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Compounds and methods for the treatment of cancer

French Title of Invention:

Composes et méthodes destines au traitement du cancer

German Title of Invention:

Verbindungen und Verfahren zur Behandlung von Krebs

SPC Number:

Dates

Filing date:

28/07/2006

Grant date:

31/12/2014

EP Publication Date:

31/12/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/12/2011

EP B1 Publication Date:

31/12/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/07/2015

Expiration date:

28/07/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/02/2015

 

 

Name:

Solasia Pharma K.K.

Address:

3F, Shiodome Building 1-2-20, Kaigan, Minato-ku, Tokyo 105-0022, Japan (JP)

Inventor

1

Name:

Renzelmann Brian

Address:

United States (US)

2

Name:

Gutsch Paul

Address:

United States (US)

Priority

Priority Number:

704163 P

Priority Date:

29/07/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 35/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages